IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Shasun Pharmaceuticals to sell Vizag plant

7:01 AM MST | December 12, 2013 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India), a leading global supplier of intermediates, active pharma ingredients (APIs) and formulations, announced today that its board of directors has approved plans to divest its Vizag, India, manufacturing  facility subject to approval from shareholders. The company announced in 2009 that it plans to build the facility with an initial production capacity of 1,200 m.t./year of bulk drugs, including generic APIs, particularly for the Japanese market. Completion of the facility was delayed several times due to several reasons...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa